-

This activity is provided by Physicians’ Education Resource®, LLC.

An application has been made to the EACCME® for CME accreditation of this event.

• Medical_Professionals
• Medical_students
• Nurses

New agents, emerging strategies, and optimization of established regimens are changing the delivery of breast cancer therapy. Over the past decade, tremendous progress in the treatment of breast cancers has led to improved outcomes for patients, but has also complicated clinical management in this setting. We are excited to announce the 1st Annual Paris Breast Cancer Conference™, a comprehensive educational conference designed to help practitioners place emerging information into the context of landmark clinical trial data and established standards of care, with the goal of ultimately improving the care they provide to their patients with breast cancers.

This practical and interactive multiday program features a faculty of leading international experts who will provide up-to-date information and guidance via didactic lectures, question-and-answer sessions, and extended interactive, case-based panel discussions. This format will enable participants to engage the faculty in a direct exchange of perspectives, personal experiences, and strategies related to clinical challenges in the management of breast cancers.

This meeting is not to be missed! The activity will to continue the legacy and tradition of Physicians’ Education Resource®, LLC, in providing clinicians with the knowledge and confidence to maintain state-of-the-art care and to optimize outcomes for patients with cancer.

Can't Miss Topics

Perspectives on emerging strategies

Immunotherapeutics for early-stage, triple-negative breast cancer (TNBC)

Antibody-drug conjugates in metastatic TNBC

Molecular testing for early human epidermal growth factor receptor 2 (HER2)-positive breast cancer

Targeted therapies for HER2-positive metastatic breast cancer

Robot-assisted surgery

Short preoperative systemic therapy for early luminal breast cancer

Genomics for hormone-receptor (HR)‒positive, metastatic breast cancer

Patient selection for carboplatin in early TNBC

How to treat residual TNBC after neoadjuvant chemotherapy

Germline alteration testing in TNBC

Clinical updates on targeted therapies including T-DM1, PI3K inhibitors, PARP inhibitors, CDK4/6 inhibition, and HER2-targeted agents

Management of brain metastases

Treatment de-escalation for small HER2-positive tumors

Updates in locoregional therapies

Practical guidance on individualizing and optimizing therapy, including endocrine and anthracycline-free regimens

Challenging case debates

Monica Arnedos, MD, PhD

Associate Professor, Department of Medical Oncology,

Breast Cancer Unit

Gustave Roussy

Villejuif, France

Evandro de Azambuja, MD, PhD

Medical Director, Breast European Adjuvant Study Team (BrEAST) Data Centre

Jules Bordet Institute

Brussels, Belgium

Thomas Bachelot, MD, PhD

Director, Breast Cancer Unit

Centre Lèon Bèrard

Lyon, France

Judith Balmaña, MD, PhD

Head, Familial Cancer Unit

Assistant Breast Cancer Unit

Vall d’Hebron University Hospital

Barcelona, Spain

Joseph Bergh, MD

Professor/Senior Physician, Department of Oncology-Pathology

Karolinska Institutet

Stockholm, Sweden

Javier Cortès, MD, PhD

Head of the Breast Cancer and Gynecological Tumors at Ramon y Cajal University Hospital in Madrid

Clinical Investigator of the Breast Cancer Research Program,

Vall d'Hebron Institute of Oncology

Barcelona, Spain

FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.

**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email info@gotoper.com, or call +1 (609) 378-3701 between 9:00 and 17:00 US EST.

A cancellation fee of 25% will be assessed on refunds requested prior to 31 August 2017, and a 50% fee on refunds requested on 1 September 2017, through 21 September 2017. No refunds will be made after 28 September 2017. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians\' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and all applicable laws, rules and regulations. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call +1 (609) 378-3701.

Physicians\' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity (“Events”), all participants, attendees, exhibitors, sponsors, and guests (“you”) create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness (“Image”). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you, and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

The Westin Paris-Vendôme

3 Rue de Castiglione

Paris, 75001, France

Tel: +33 (0) 1 44 77 11 11

The Westin Paris-Vendôme is centrally located in Paris' 1st Arrondissement. The hotel is only a 10-minute walk to Place de la Concorde, the Louvre Museum and the Place Vendôme.

Be sure to mention the Paris Breast Cancer Conference™ when making reservations to receive the discounted rate.

Room Rates

A limited block of rooms has been set aside at The Westin Paris-Vendôme at a run-of-house rate of €330 single/€350 double (includes daily breakfast, state and local taxes). Rates and rooms are subject to availability at the time of the reservation.

The deadline for making your hotel reservations is 25th September 2017. After that date, or in the event that the room block becomes full prior to the deadline, rooms are subject to availability, and the room rates may increase. When booking, please mention the 1st Annual Paris Breast Cancer Conference™ to receive the discounted group rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card.

Check-in is 16:00, and check out is 10:00.

Submission Info

Please email grants@gotoper.com for information about this upcoming conference.

Exhibitors

Exhibit at this year's meeting and increase your visibility.

Our custom sponsorship packages provide outstanding recognition and increased awareness of your company’s products and services. Don’t miss this opportunity to reach this important target audience.

For additional details, contact:

Beth Conway | National Accounts Associate

OncLive® Events & Intellisphere Oncology Specialty Group

Cell: +1 (609) 664-7651

Email: econway@onclive.com

Jessica Cortese | National Accounts Associate

OncLive® Events & Intellisphere Oncology Specialty Group

Cell: +1 (908) 217-6085

Email: jcortese@onclive.com

OncLive® Events & Intellisphere Oncology Specialty Group

2 Clarke Drive, Suite 100, Cranbury, NJ 08512

Web: http://www.onclive.com

Physicians' Education Resource, LLC

Phone: 609-378-3701

Fax: 609-257-0705

Email: info@gotoper.com